{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T02:30:24Z","timestamp":1747189824495},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T00:00:00Z","timestamp":1327536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00108-011-2981-6","type":"journal-article","created":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T07:21:21Z","timestamp":1327389681000},"page":"309-318","source":"Crossref","is-referenced-by-count":2,"title":["Kardiorenales Syndrom"],"prefix":"10.1007","volume":"53","author":[{"given":"M.D.","family":"Alscher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Sechtem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,26]]},"reference":[{"key":"2981_CR1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12181-009-0219-9","volume":"3","author":"Alscher","year":"2009","unstructured":"Alscher MD (2009) Herz und Niere \u2013 von der Risikostratifikation bis zu Wechselwirkungen der medikament\u00f6sen Therapie. Kardiologe 3:489\u2013498","journal-title":"Kardiologe"},{"key":"2981_CR2","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","volume":"377","author":"Baigent","year":"2011","unstructured":"Baigent C, Landray MJ, Reith C et al (2011) The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 377:2181\u20132192","journal-title":"Lancet"},{"key":"2981_CR3","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038\u20132047","journal-title":"JAMA"},{"key":"2981_CR4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","volume":"49","author":"Costanzo","year":"2007","unstructured":"Costanzo MR, Guglin ME, Saltzberg MT et al (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49:675\u2013683","journal-title":"J Am Coll Cardiol"},{"key":"2981_CR5","doi-asserted-by":"crossref","first-page":"c4986","DOI":"10.1136\/bmj.c4986","volume":"341","author":"Di","year":"2010","unstructured":"Di Angelantonio E, Chowdhury R, Sarwar N et al (2010) Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ 341:c4986","journal-title":"BMJ"},{"key":"2981_CR6","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","volume":"32","author":"European","year":"2011","unstructured":"European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G et al (2011) ESC\/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 32:1769\u20131818","journal-title":"Eur Heart J"},{"key":"2981_CR7","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.02.047","volume":"53","author":"Hage","year":"2009","unstructured":"Hage FG, Venkataraman R, Zoghbi GJ et al (2009) The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol 53:2129\u20132140","journal-title":"J Am Coll Cardiol"},{"key":"2981_CR8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jacc.2008.11.012","volume":"53","author":"Jessup","year":"2009","unstructured":"Jessup M, Costanzo MR (2009) The cardiorenal syndrome: do we need a change of strategy or a change of tactics? J Am Coll Cardiol 53:597\u2013599","journal-title":"J Am Coll Cardiol"},{"key":"2981_CR9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrneph.2009.210","volume":"6","author":"Lameire","year":"2010","unstructured":"Lameire N, Van Biesen W (2010) Epidemiology of peritoneal dialysis: a story of believers and nonbelievers. Nat Rev Nephrol 6:75\u201382","journal-title":"Nat Rev Nephrol"},{"key":"2981_CR10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.ki.5001918","volume":"Suppl","author":"Mehrotra","year":"2006","unstructured":"Mehrotra R, Kathuria P (2006) Place of peritoneal dialysis in the management of treatment-resistant congestive heart failure. Kidney Int Suppl (103):67\u201371","journal-title":"Kidney Int"},{"key":"2981_CR11","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","volume":"11","author":"Mehta","year":"2007","unstructured":"Mehta RL, Kellum JA, Shah SV et al (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31","journal-title":"Crit Care"},{"key":"2981_CR12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ccl.2011.03.004","volume":"29","author":"Mentz","year":"2011","unstructured":"Mentz RJ, Lewis EF (2011) Epidemiology of cardiorenal syndrome. Cardiol Clin 29:301\u2013314","journal-title":"Cardiol Clin"},{"key":"2981_CR13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","volume":"93","author":"Mosterd","year":"2007","unstructured":"Mosterd A, Hoes AW (2007) Clinical epidemiology of heart failure. Heart 93:1137\u20131146","journal-title":"Heart"},{"key":"2981_CR14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","volume":"53","author":"Mullens","year":"2009","unstructured":"Mullens W, Abrahams Z, Francis GS et al (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53:589\u2013596","journal-title":"J Am Coll Cardiol"},{"key":"2981_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacc.2008.09.055","volume":"53","author":"Orasanu","year":"2009","unstructured":"Orasanu G, Plutzky J (2009) The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 53:35\u201342","journal-title":"J Am Coll Cardiol"},{"key":"2981_CR16","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/archinte.167.18.1930","volume":"167","author":"Phillips","year":"2007","unstructured":"Phillips CO, Kashani A, Ko DK et al (2007) Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials. Arch Intern Med 167:1930\u20131936","journal-title":"Arch Intern Med"},{"key":"2981_CR17","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","volume":"123","author":"Roger","year":"2011","unstructured":"Roger VL, Go AS, Lloyd-Jones DM et al (2011) Heart disease and stroke statistics \u2013 2011 update: a report from the American Heart Association. Circulation 123:e18\u2013e209","journal-title":"Circulation"},{"key":"2981_CR18","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","volume":"52","author":"Ronco","year":"2008","unstructured":"Ronco C, Haapio M, House AA et al (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527\u20131539","journal-title":"J Am Coll Cardiol"},{"key":"2981_CR19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/ndt\/gfp484","volume":"25","author":"Sanchez","year":"2010","unstructured":"Sanchez JE, Ortega T, Rodriguez C et al (2010) Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. Nephrol Dial Transplant 25:605\u2013610","journal-title":"Nephrol Dial Transplant"},{"key":"2981_CR20","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","volume":"108","author":"Sarnak","year":"2003","unstructured":"Sarnak MJ, Levey AS, Schoolwerth AC et al (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108:2154\u20132169","journal-title":"Circulation"},{"key":"2981_CR21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7326\/0003-4819-138-11-200306030-00013","volume":"138","author":"Shlipak","year":"2003","unstructured":"Shlipak MG (2003) Pharmacotherapy for heart failure in patients with renal insufficiency. Ann Intern Med 138:917\u2013924","journal-title":"Ann Intern Med"},{"key":"2981_CR22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/bmj.39472.580984.AE","volume":"336","author":"Strippoli","year":"2008","unstructured":"Strippoli GF, Navaneethan SD, Johnson DW et al (2008) Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ 336:645\u2013651","journal-title":"BMJ"},{"key":"2981_CR23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/hrt.2009.166256","volume":"96","author":"Tang","year":"2010","unstructured":"Tang WH, Mullens W (2010) Cardiorenal syndrome in decompensated heart failure. Heart 96:255\u20132560","journal-title":"Heart"},{"key":"2981_CR24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","volume":"353","author":"Wanner","year":"2005","unstructured":"Wanner C, Krane V, Marz W et al (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353:238\u2013248","journal-title":"N Engl J Med"},{"key":"2981_CR25","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","volume":"358","author":"Yusuf","year":"2008","unstructured":"Yusuf S, Teo KK, Pogue J et al (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358:1547\u20131559","journal-title":"N Engl J Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-011-2981-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-011-2981-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-011-2981-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:12:24Z","timestamp":1558584744000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-011-2981-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,26]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["2981"],"URL":"https:\/\/doi.org\/10.1007\/s00108-011-2981-6","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,26]]}}}